# Aphexda

NDC: 82737-073
Generic name: Motixafortide
Labeler / Manufacturer: BioLineRx USA Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230908

FDA application: NDA217159

## Active ingredients

- MOTIXAFORTIDE ACETATE: 62 mg/1.7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82737-073"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82737-073
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7cdc584-ebf0-a68e-e053-6294a90a9ea9